Work

Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness

Year: 2009

Type: article

Abstract: The early 21st century has witnessed the maturation of HIV, HBV and HCV epidemics with respect to disease recognition, understanding and medical treatment. Most notably, the availability of safe, potent antiretroviral therapy (ART) in settings with adequate resources has transformed HIV infection into a chronic disease that, for many infected patients, may not substantially limit life expectancy [1,2]. Consequently, chronic medical conditions such as diabetes mellitus, hypertension, coronary artery disease, viral hepatitis-related liver disease and malignancy have emerged as major causes of morbidity and mortality in HIV-infected patients; many of whom are over the age of 50 [3–7].

Source: Journal of Hepatology

DOI: 10.1016/j.jhep.2009.01.009

Author: Mark Sulkowski

Institutions: Johns Hopkins University, Johns Hopkins Medicine

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $5,500